GPC3 and hepatocellular carcinoma: We previously provided proof-of-concept that PET imaging of HCC using 89Zr-radiolabeled murine anti-GPC3 antibody (clone 1G12) could successfully delineate orthotopic patient-derived HCC xenografts from normal liver [14].